Search Results

Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.

The Laurie K. Lacob Pavilion at the Stanford Medicine Cancer Center opened July 17. The state-of-the-art facility, for transplant and cellular therapies, is a light-filled space for healing.

Stanford Medicine researchers find that using in vitro fertilization with testing embryos for inherited diseases would significantly reduce costs.

An international effort led by a Stanford Medicine researcher finds more than 50 genes linked to glioma — a rare brain cancer. Although most gliomas are sporadic, a minority are inherited.

A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.

Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

Stanford scientists have developed a device that delivers and electrically stimulates stem cells to promote stroke healing.

The Stanford Cancer Institute is one of 51 National Cancer Institute-designated comprehensive cancer centers, which must meet rigorous standards for improving the prevention, diagnosis and treatment of cancer.

Stanford researcher Maria Grazia Roncarolo has been awarded $12 million by the California Institute for Regenerative Medicine for a trial aimed at improving the outcomes of stem cell transplants in children and young adults with blood cancers.

New Stanford graduate Nico Poux, a former pediatric oncology patient at Lucile Packard Children’s Hospital Stanford, hopes to bring his experience with cancer to future work as a physician-scientist.